Male breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human

Organisms1

Diseases25

Breast Neoplasms, Male Gynecomastia Breast Neoplasms Carcinoma, Ductal, Breast Carcinoma, Intraductal, Noninfiltrating Breast Diseases Lymphatic Metastasis Genetic Predisposition to Disease Neoplasm Metastasis Neoplasm Invasiveness Ovarian Neoplasms Carcinoma, Lobular Adenocarcinoma Carcinoma Neoplasms, Ductal, Lobular, and Medullary Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Breast Cyst Neoplasm Recurrence, Local Prostatic Neoplasms Fibrocystic Breast Disease Lung Neoplasms Disease Progression Neoplasms Bone Neoplasms

Chemicals and Drugs25

BRCA2 Protein Receptors, Estrogen Receptors, Progesterone Receptor, erbB-2 Tamoxifen Antineoplastic Agents, Hormonal TNF Receptor-Associated Factor 4 Neoplasm Proteins Tumor Markers, Biological BRCA1 Protein Antineoplastic Agents Estrogens Transcription Factors Estrogen Receptor alpha Ki-67 Antigen Aromatase Inhibitors RNA, Messenger Estrogen Antagonists DNA, Neoplasm Keratin-6 Tumor Suppressor Protein p53 Estradiol Fluorouracil RNA, Small Interfering Antibodies, Monoclonal, Humanized

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Mastectomy Prognosis Neoplasm Staging Risk Factors Mammography Survival Rate Immunohistochemistry Retrospective Studies Incidence Case-Control Studies Follow-Up Studies Kaplan-Meier Estimate Tissue Array Analysis Registries Chemotherapy, Adjuvant DNA Mutational Analysis Early Detection of Cancer Treatment Outcome Survival Analysis Mastectomy, Modified Radical Pedigree Disease-Free Survival Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Ultrasonography, Mammary Breast Self-Examination Mammary Neoplasms, Experimental Risk Mastectomy, Radical Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Risk Assessment Mastectomy, Segmental Biopsy, Needle Odds Ratio Combined Modality Therapy Genetic Testing Radiotherapy, Adjuvant Xenograft Model Antitumor Assays Blotting, Western Cohort Studies Multivariate Analysis Sensitivity and Specificity Neoplasm Transplantation Biopsy

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes20

Genes, BRCA2 Genes, BRCA1 Germ-Line Mutation Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Mutation Postmenopause Breast Feeding Premenopause Drug Resistance, Neoplasm Risk Exons Cell Proliferation Menopause Genes, erbB-2 Odds Ratio Time Factors Apoptosis Signal Transduction Sensitivity and Specificity

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Incidence Registries

Named Groups1

Health Care20

Risk Factors Survival Rate Age Factors Retrospective Studies Incidence Case-Control Studies Follow-Up Studies Kaplan-Meier Estimate Registries Treatment Outcome Survival Analysis Disease-Free Survival Risk Prospective Studies Risk Assessment Odds Ratio Genetic Testing Cohort Studies Multivariate Analysis Sensitivity and Specificity

Geographicals2

Italy United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Breast Neoplasms, Male Gynecomastia Breast Breast Neoplasms BRCA2 Protein Carcinoma, Ductal, Breast Genes, BRCA2 Receptors, Estrogen Mastectomy Genes, BRCA1 Carcinoma, Intraductal, Noninfiltrating Receptors, Progesterone Receptor, erbB-2 Tamoxifen Antineoplastic Agents, Hormonal Germ-Line Mutation Breast Diseases Prognosis TNF Receptor-Associated Factor 4 Neoplasm Proteins Tumor Markers, Biological Neoplasm Staging Risk Factors Lymphatic Metastasis BRCA1 Protein Cell Line, Tumor Mammography Genetic Predisposition to Disease Gene Expression Regulation, Neoplastic Survival Rate Immunohistochemistry Neoplasm Metastasis Age Factors Retrospective Studies Neoplasm Invasiveness Ovarian Neoplasms Incidence Carcinoma, Lobular Case-Control Studies Follow-Up Studies Kaplan-Meier Estimate Tissue Array Analysis Mutation Registries Adenocarcinoma Chemotherapy, Adjuvant DNA Mutational Analysis Early Detection of Cancer Treatment Outcome Survival Analysis Antineoplastic Agents Estrogens Postmenopause Carcinoma Mastectomy, Modified Radical Pedigree Disease-Free Survival Transcription Factors MCF-7 Cells Italy Gene Expression Profiling Mice, Nude Breast Feeding Premenopause Tumor Cells, Cultured Antineoplastic Combined Chemotherapy Protocols Estrogen Receptor alpha Ultrasonography, Mammary Drug Resistance, Neoplasm Neoplasms, Ductal, Lobular, and Medullary Breast Self-Examination Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Risk Exons Cell Proliferation Breast Cyst Neoplasm Recurrence, Local Menopause Prostatic Neoplasms Ki-67 Antigen Mastectomy, Radical Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Fibrocystic Breast Disease Aromatase Inhibitors RNA, Messenger Risk Assessment Estrogen Antagonists Lung Neoplasms Survivors Mastectomy, Segmental Axilla Disease Progression Biopsy, Needle Genes, erbB-2 Odds Ratio United States Neoplasms Combined Modality Therapy

No FAQ available that match "male breast cancer"